SG11201404378XA - Probiotic derived non-viable material for infection prevention and treatment - Google Patents
Probiotic derived non-viable material for infection prevention and treatmentInfo
- Publication number
- SG11201404378XA SG11201404378XA SG11201404378XA SG11201404378XA SG11201404378XA SG 11201404378X A SG11201404378X A SG 11201404378XA SG 11201404378X A SG11201404378X A SG 11201404378XA SG 11201404378X A SG11201404378X A SG 11201404378XA SG 11201404378X A SG11201404378X A SG 11201404378XA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- infection prevention
- derived non
- viable material
- probiotic derived
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pediatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12161083 | 2012-03-23 | ||
| PCT/US2013/032757 WO2013142403A1 (en) | 2012-03-23 | 2013-03-18 | Probiotic derived non-viable material for infection prevention and treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201404378XA true SG11201404378XA (en) | 2014-08-28 |
Family
ID=48045112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201404378XA SG11201404378XA (en) | 2012-03-23 | 2013-03-18 | Probiotic derived non-viable material for infection prevention and treatment |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20130251829A1 (en) |
| EP (1) | EP2827725A1 (en) |
| CN (2) | CN108714157A (en) |
| AR (1) | AR090473A1 (en) |
| AU (1) | AU2013235365B2 (en) |
| CA (1) | CA2868109A1 (en) |
| CO (1) | CO7151477A2 (en) |
| EC (1) | ECSP14024082A (en) |
| HK (1) | HK1204869A1 (en) |
| MX (1) | MX360591B (en) |
| MY (1) | MY169754A (en) |
| NZ (1) | NZ627915A (en) |
| PE (1) | PE20142276A1 (en) |
| PH (1) | PH12014502112A1 (en) |
| RU (1) | RU2014137188A (en) |
| SG (1) | SG11201404378XA (en) |
| TW (1) | TWI587864B (en) |
| WO (1) | WO2013142403A1 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
| US20150157048A1 (en) | 2013-12-11 | 2015-06-11 | Mead Johnson Nutrition Company | Nutritional compositions containing stearidonic acid and uses thereof |
| US20150290261A1 (en) * | 2014-04-10 | 2015-10-15 | Mead Johnson Nutrition Company | Methods of use for probiotics and prebiotics |
| US20150305385A1 (en) | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| US20160029682A1 (en) | 2014-08-01 | 2016-02-04 | Mead Johnson Nutrition Company | Hydrolyzed lactose-containing nutritional compositions and uses thereof |
| US20160095339A1 (en) | 2014-10-01 | 2016-04-07 | Mead Johnson Nutrition Company | Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile |
| US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
| US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
| US20180064739A1 (en) | 2016-09-06 | 2018-03-08 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
| US20180103675A1 (en) | 2016-10-14 | 2018-04-19 | Mead Johnson Nutrition Company | Personalized pediatric nutrition products comprising human milk oligosaccharides |
| US20180160714A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
| US20180161292A1 (en) | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions containing butyrate and uses thereof |
| US20180161381A1 (en) * | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions and methods for reducing the occurrence or severity of viral infections, bacterial infections and viral and bacterial co-infections |
| US10980269B2 (en) | 2016-12-12 | 2021-04-20 | Mead Johnson Nutrition Company | Protein hydrolysates and methods of making same |
| US20180168215A1 (en) | 2016-12-21 | 2018-06-21 | Mead Johnson Nutrition Company | Nutritional compositions containing inositol and uses thereof |
| US20180332881A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Preterm infant formula containing butyrate and uses thereof |
| US20180333426A1 (en) | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
| CN107812018A (en) * | 2017-11-13 | 2018-03-20 | 浙江禾健生营养食品有限公司 | A kind of inactivated probiotic product, preparation method and applications |
| US20190208807A1 (en) * | 2018-01-05 | 2019-07-11 | Mead Johnson Nutrition Company | Nutritional compositions containing milk-derived peptides and uses thereof |
| GB2573538B (en) | 2018-05-09 | 2023-01-04 | Mjn Us Holdings Llc | Pediatric nutritional compositions and methods for infants delivered by C-section |
| WO2024124272A1 (en) * | 2022-12-14 | 2024-06-20 | BiomeMega Pty Ltd | Compositions containing probiotic supernatants |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839281A (en) * | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| EP1787532A3 (en) | 1991-01-24 | 2010-03-31 | Martek Biosciences Corporation | Microbial oil mixtures and uses thereof |
| US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
| FI104465B (en) * | 1995-06-14 | 2000-02-15 | Valio Oy | Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use |
| CN1164186C (en) * | 2001-04-29 | 2004-09-01 | 上海光明乳业股份有限公司 | Milk with probiotics and its production process |
| EP1384483A1 (en) | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
| US7407652B2 (en) * | 2005-06-03 | 2008-08-05 | Aquatechnics Inc. | Probiotic system for aquaculture |
| WO2007057872A2 (en) * | 2005-11-21 | 2007-05-24 | Teagasc-National Diary Products Research Centre | Casein-derived antimicrobial peptides and lactobacillus strains that produce them |
| MX2009008875A (en) * | 2007-02-28 | 2009-08-28 | Mead Johnson Nutrition Co | Product containing inactivated probiotic for children or infants. |
| US20080254011A1 (en) * | 2007-04-11 | 2008-10-16 | Peter Rothschild | Use of selected lactic acid bacteria for reducing atherosclerosis |
| RU2350648C1 (en) * | 2007-09-14 | 2009-03-27 | Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук | Method of estimation of probiotics opposing activity on basis of lyophilised biomass of anaerobic bacteria in relation to pathogenic micobacteria |
| EP2130440A1 (en) | 2008-06-06 | 2009-12-09 | N.V. Nutricia | Inhibiting E. sakazakii growth |
| US8137718B2 (en) * | 2008-09-19 | 2012-03-20 | Mead Johnson Nutrition Company | Probiotic infant products |
| EP2295535A1 (en) * | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
| US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
| CN104531562B (en) * | 2014-12-09 | 2018-09-14 | 北京农学院 | A kind of preparation method of lactobacillus plantarum plant subspecies and its anti-Listeria monocytogenes bacteriocin |
-
2013
- 2013-03-15 US US13/832,828 patent/US20130251829A1/en not_active Abandoned
- 2013-03-18 CN CN201810544250.XA patent/CN108714157A/en active Pending
- 2013-03-18 CA CA2868109A patent/CA2868109A1/en not_active Abandoned
- 2013-03-18 RU RU2014137188A patent/RU2014137188A/en not_active Application Discontinuation
- 2013-03-18 AU AU2013235365A patent/AU2013235365B2/en not_active Ceased
- 2013-03-18 MX MX2014010150A patent/MX360591B/en active IP Right Grant
- 2013-03-18 NZ NZ627915A patent/NZ627915A/en not_active IP Right Cessation
- 2013-03-18 EP EP13713686.7A patent/EP2827725A1/en not_active Withdrawn
- 2013-03-18 MY MYPI2014702147A patent/MY169754A/en unknown
- 2013-03-18 WO PCT/US2013/032757 patent/WO2013142403A1/en active Application Filing
- 2013-03-18 CN CN201380015996.7A patent/CN104219968A/en active Pending
- 2013-03-18 SG SG11201404378XA patent/SG11201404378XA/en unknown
- 2013-03-18 PE PE2014001463A patent/PE20142276A1/en not_active Application Discontinuation
- 2013-03-21 TW TW102110056A patent/TWI587864B/en not_active IP Right Cessation
- 2013-03-22 AR ARP130100945A patent/AR090473A1/en unknown
-
2014
- 2014-09-09 CO CO14198811A patent/CO7151477A2/en unknown
- 2014-09-23 PH PH12014502112A patent/PH12014502112A1/en unknown
- 2014-10-23 EC ECIEPI201424082A patent/ECSP14024082A/en unknown
-
2015
- 2015-06-12 HK HK15105581.7A patent/HK1204869A1/en unknown
-
2017
- 2017-02-21 US US15/438,223 patent/US20170157185A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CO7151477A2 (en) | 2014-12-29 |
| US20130251829A1 (en) | 2013-09-26 |
| PE20142276A1 (en) | 2015-01-23 |
| TW201400124A (en) | 2014-01-01 |
| PH12014502112A1 (en) | 2014-12-10 |
| AU2013235365B2 (en) | 2016-05-19 |
| CA2868109A1 (en) | 2013-09-26 |
| MY169754A (en) | 2019-05-15 |
| MX360591B (en) | 2018-11-09 |
| CN108714157A (en) | 2018-10-30 |
| ECSP14024082A (en) | 2015-09-30 |
| EP2827725A1 (en) | 2015-01-28 |
| NZ627915A (en) | 2016-07-29 |
| AR090473A1 (en) | 2014-11-12 |
| TWI587864B (en) | 2017-06-21 |
| MX2014010150A (en) | 2014-09-16 |
| WO2013142403A1 (en) | 2013-09-26 |
| HK1204869A1 (en) | 2015-12-11 |
| RU2014137188A (en) | 2016-05-20 |
| CN104219968A (en) | 2014-12-17 |
| US20170157185A1 (en) | 2017-06-08 |
| AU2013235365A1 (en) | 2014-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1204869A1 (en) | Probiotic derived non-viable material for infection prevention and treatment | |
| HK1253343A1 (en) | Novel depsipeptide and uses thereof | |
| HK1203449A1 (en) | Azetidinium-containing copolymers and uses thereof | |
| GB201206599D0 (en) | Probiotic bacteria | |
| SG10201503351RA (en) | Engineered Opsonin for Pathogen Detection and Treatment | |
| EP2819611A4 (en) | Dental products and procedures | |
| EP2804550A4 (en) | Medical device and methods | |
| PL2685994T3 (en) | Probiotic bacteria having antioxidant activity and use thereof | |
| EP2920578A4 (en) | Post-steam sterilization moisture-indicating methods and articles | |
| ZA201405858B (en) | Recombinant microorganisms and methods of use thereof | |
| EP2714055A4 (en) | Biocompatible material and uses thereof | |
| EP2902042A4 (en) | Sterilization method and device | |
| HK1200949A1 (en) | Material lifting system and method | |
| PL2857045T3 (en) | Sterilization device and sterilization method using same | |
| SG11201504542PA (en) | Probiotic strains for the treatment and/or prevention of diarrhœa | |
| EP2749302A4 (en) | Antithrombogenic material and medical device | |
| HK1211221A1 (en) | Formulations for the treatment and prevention of obesity | |
| EP2844258A4 (en) | Methods and compositions for treating bacterial infection | |
| HK1210809A1 (en) | Beta-hexosyl-transferases and uses thereof | |
| EP2938415A4 (en) | Materials and methods | |
| EP2883553A4 (en) | Processing method and processing device for implant material having excellent biocompatibility | |
| EP2813531A4 (en) | Stimuli-responsive material and medical material comprising same | |
| HUE036643T2 (en) | Material for surface treatment and its application | |
| HK1176343A1 (en) | Modified grapheme and preparation method thereof | |
| EP2907890A4 (en) | Pvd treatment method and pvd treatment device |